We compared annual fuel costs for the best-selling cars in South Africa to comparable hybrid electric vehicles.
These preclinical data underscore the potential of ORIC-944 to overcome resistance not only in prostate cancer but in other solid tumors and highlight that the therapeutic potential of PRC2 inhibition ...
KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid ...
Q3 2025 Earnings Call October 27, 2025 8:00 AM EDTCompany ParticipantsStephen Willoughby - Senior VP of Investor Relations ...
KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to appro ...
MAIA also announced that it has enrolled five patients from Taiwan and Turkey in the expansion phase of its THIO-101 Phase 2 trial. Screening for the trial is ongoing in Europe and Asia. With ...
The Global Optogenetics Equipment Market was valued at USD 400 million in 2024 and is projected to reach USD 1.2 billion by 2033, growing at a CAGR of 15.5% from 2026 to 2033. This strong growth ...
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented posters at the 2025 EORTC-NCI ...
The Ovulation Test Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2033, reflecting a robust CAGR of 7.5% between 2026 and 2033. This growth is driven by ...
After taking the world by storm with last year's model, Google's Pixel 10 Pro Fold had some big shoes to fill. It gets fairly ...